AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
23
Employees23
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
23
Employees23

AIM Key Statistics

Market cap
6.60M
Market cap6.60M
Price-Earnings ratio
-0.11
Price-Earnings ratio-0.11
Dividend yield
—
Dividend yield—
Average volume
808.38K
Average volume808.38K
High today
$3.08
High today$3.08
Low today
$2.76
Low today$2.76
Open price
$3.04
Open price$3.04
Volume
134.89K
Volume134.89K
52 Week high
$39.95
52 Week high$39.95
52 Week low
$2.51
52 Week low$2.51

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
Plug Power
Inovio
Aurora Cannabis
Workhorse
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.